WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |

Search International and National Patent Collections
World Intellectual Property Organization
Machine translation
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/041375    International Application No.:    PCT/US1999/002572
Publication Date: 19.08.1999 International Filing Date: 05.02.1999
Chapter 2 Demand Filed:    10.09.1999    
A61K 38/00 (2006.01), C07K 14/705 (2006.01)
Applicants: INCYTE PHARMACEUTICALS, INC. [US/US]; 3174 Porter Drive Palo Alto, CA 94304 (US) (For All Designated States Except US).
HILLMAN, Jennifer, L. [US/US]; (US) (For US Only).
BANDMAN, Olga [US/US]; (US) (For US Only).
YUE, Henry [US/US]; (US) (For US Only).
GUEGLER, Karl, J. [CH/US]; (US) (For US Only).
CORLEY, Neil, C. [US/US]; (US) (For US Only).
AU-YOUNG, Janice [US/US]; (US) (For US Only).
TANG, Y., Tom [CN/US]; (US) (For US Only).
SHAH, Purvi [IN/US]; (US) (For US Only).
LAL, Preeti [IN/US]; (US) (For US Only).
BAUGHN, Mariah [US/US]; (US) (For US Only)
Inventors: HILLMAN, Jennifer, L.; (US).
BANDMAN, Olga; (US).
YUE, Henry; (US).
GUEGLER, Karl, J.; (US).
CORLEY, Neil, C.; (US).
AU-YOUNG, Janice; (US).
TANG, Y., Tom; (US).
SHAH, Purvi; (US).
LAL, Preeti; (US).
BAUGHN, Mariah; (US)
Agent: BILLINGS, Lucy, J.; Incyte Pharmaceuticals, Inc. 3174 Porter Drive Palo Alto, CA 94304 (US)
Priority Data:
09/022,939 12.02.1998 US
Abstract: front page image
(EN)The invention provides human receptor proteins (HURP) and polynucleotides which identify and encode HURP. The invention also provides expression vectors, host cells, antibodies, agonists, and antagonists. The invention also provides methods for treating or preventing disorders associated with expression of HURP.
(FR)L'invention concerne des protéines réceptrices humaines ainsi que des polynucléotides qui identifient et codent ces protéines. L'invention concerne également des vecteurs d'expression, des cellules hôtes, des anticorps, des agonistes et des antagonistes. Elle concerne encore des procédés de traitement ou de prévention de troubles associés à l'expression de ces protéines.
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)